{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:49:15Z","timestamp":1789516155917,"version":"build-2803163510"},"reference-count":40,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["J Dev Orig Health Dis"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The epidemic of prescription and non-prescription opioid misuse is of particular importance in pregnancy. The Society of Obstetricians and Gynaecologists of Canada currently recommends opioid replacement therapy with methadone or buprenorphine for opioid-dependent women during pregnancy. This vulnerable segment of the population has been shown to be at increased risk of blood-borne infectious diseases, nutritional insecurity and stress. The objective of this study was to describe an urban cohort of pregnant women on opioid replacement therapy and to evaluate potential effects on the fetus. A retrospective chart review of all women on opioid replacement therapy and their infants who delivered at The Ottawa Hospital General and Civic campuses between January 1, 2013 and March 24, 2017 was conducted. Data were collected on maternal characteristics, pregnancy outcomes, neonatal outcomes and corresponding placental pathology. Maternal comorbidities identified included high rates of infection, tobacco use and illicit substance use, as well as increased rates of placental abruption compared with national averages. Compared with national baseline averages, the mean neonatal birth weight was low, and the incidence of small for gestational age infants and congenital anomalies was high. The incidence of NAS was comparable with estimates from other studies of similar cohorts. Findings support existing literature that calls for a comprehensive interdisciplinary risk reduction approach including dietary, social, domestic, psychological and other supports to care for opioid-dependent women in pregnancy.<\/jats:p>","DOI":"10.1017\/s2040174418000478","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T14:20:22Z","timestamp":1534429222000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":13,"title":["Maternal and neonatal characteristics of a Canadian urban cohort receiving treatment for opioid use disorder during pregnancy"],"prefix":"10.1017","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-9841","authenticated-orcid":false,"given":"C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Grynspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lafreniere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lattuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"key":"S2040174418000478_ref25","unstructured":"Statistics Canada, Canadian Vital Statistics, Birth Database. CANSIM table 102-4317."},{"key":"S2040174418000478_ref28","unstructured":"Harper PS . Practical Genetic Counselling, 5th edition, 1998. Butterworth Heinemann: Boston, 56\u201370."},{"key":"S2040174418000478_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.12.019"},{"key":"S2040174418000478_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3782(77)90017-2"},{"key":"S2040174418000478_ref2","unstructured":"Public Health Ontario. Opioid-related morbidity and mortality in Ontario. 2017. Retrieved 5 September 2017 from https:\/\/www.publichealthontario.ca\/en\/dataandanalytics\/pages\/opioid.aspx."},{"key":"S2040174418000478_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.06.019"},{"key":"S2040174418000478_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.12.016"},{"key":"S2040174418000478_ref39","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2015.1088630"},{"key":"S2040174418000478_ref16","unstructured":"Royal College of Obstetricians and Gynaecologists UK, Green-top Guideline No. 31: the Investigation and Management of the Small-for Gestational-age Fetus, 2013."},{"key":"S2040174418000478_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2007.10.007"},{"key":"S2040174418000478_ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125246"},{"key":"S2040174418000478_ref1","unstructured":"United Nations Office on Drug and Crime. World Drug Report, 2016. United Nations Publication: New York."},{"key":"S2040174418000478_ref12","doi-asserted-by":"publisher","DOI":"10.3109\/09513590902898221"},{"key":"S2040174418000478_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2005.12.006"},{"key":"S2040174418000478_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(80)90628-6"},{"key":"S2040174418000478_ref37","doi-asserted-by":"publisher","DOI":"10.3390\/nu7115467"},{"key":"S2040174418000478_ref34","doi-asserted-by":"crossref","unstructured":"Cheschier N . ACOG committee on practice bulletins-obstetrics. ACOG practice bulletin. Neural tube defects. Number 44, July 2003 (Replaces committee opinion number 252, March 2001). Int J Gynecol Obstet. 2003; 83: 123\u2013133.","DOI":"10.1016\/S0020-7292(03)00390-4"},{"key":"S2040174418000478_ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"S2040174418000478_ref21","first-page":"279","article-title":"Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption","volume":"78","author":"Hoskins","year":"1991","journal-title":"Obset Gynecol"},{"key":"S2040174418000478_ref24","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2009.1716"},{"key":"S2040174418000478_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.10.897"},{"key":"S2040174418000478_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30588-0"},{"key":"S2040174418000478_ref5","first-page":"190","article-title":"Substance use in pregnancy","volume":"256","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"S2040174418000478_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2016.11.009"},{"key":"S2040174418000478_ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/195954"},{"key":"S2040174418000478_ref36","doi-asserted-by":"crossref","unstructured":"Statistics Canada. Preterm live births in Canada, 2000\u20132013. October 26, 2016.","DOI":"10.1787\/instinv-2015-4-en"},{"key":"S2040174418000478_ref31","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2011.635324"},{"key":"S2040174418000478_ref4","first-page":"1","article-title":"Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population","volume":"6","author":"Jumah","year":"2016","journal-title":"BMJ"},{"key":"S2040174418000478_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.06.026"},{"key":"S2040174418000478_ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"S2040174418000478_ref32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8644(199811)107:3<351::AID-AJPA10>3.0.CO;2-7"},{"key":"S2040174418000478_ref35","unstructured":"Statistics Canada. Canadian Vital Statistics, Birth Database. CANSIM table 102-4510."},{"key":"S2040174418000478_ref18","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0225-CC"},{"key":"S2040174418000478_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80830-X"},{"key":"S2040174418000478_ref30","first-page":"1","article-title":"Dietary intake among opioid- and alcohol-using pregnant women","author":"Shrestha","year":"2017","journal-title":"Subst Use Misuse"},{"key":"S2040174418000478_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.12.039"},{"key":"S2040174418000478_ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1996.tb03601.x"},{"key":"S2040174418000478_ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-016-1970-8"},{"key":"S2040174418000478_ref38","doi-asserted-by":"publisher","DOI":"10.3945\/jn.114.194639"},{"key":"S2040174418000478_ref17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3212"}],"container-title":["Journal of Developmental Origins of Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2040174418000478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T10:56:46Z","timestamp":1751799406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2040174418000478\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2040174418000478"],"URL":"https:\/\/doi.org\/10.1017\/s2040174418000478","relation":{},"ISSN":["2040-1744","2040-1752"],"issn-type":[{"value":"2040-1744","type":"print"},{"value":"2040-1752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"\u00a9 Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}